The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kondratieva E.A.

Polenov Neurosurgical Institute branch of Almazov National Medical Research Centre

Kondratev S.A.

Polenov Neurosurgical Institute branch of Almazov National Medical Research Centre

Denisova A.A.

Admiral Makarov State University of Maritime and Inland Shipping

Ivanova N.E.

Polenov Russian Scientific Research Neurosurgical Institute — branch of Almazov National Medical Research Center

Kondratiev A.N.

Polenov Neurosurgical Institute

Results of treatment with intravenous amantadine sulfate (PK-Merz) patients with chronic disorders of consciousness

Authors:

Kondratieva E.A., Kondratev S.A., Denisova A.A., Ivanova N.E., Kondratiev A.N.

More about the authors

Read: 5740 times


To cite this article:

Kondratieva EA, Kondratev SA, Denisova AA, Ivanova NE, Kondratiev AN. Results of treatment with intravenous amantadine sulfate (PK-Merz) patients with chronic disorders of consciousness. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12):102‑108. (In Russ.)
https://doi.org/10.17116/jnevro2020120121102

Recommended articles:
The FOUR scale in asse­ssing patients with acute cere­bral insu­fficiency. Burdenko's Journal of Neurosurgery. 2026;(1):57-64

References:

  1. Piradov MA, Suponeva NA, Voznjuk IA, et al. Chronic disorders of consciousness: terminology and diagnostic criteria The results of the first meeting of the Russian Working Group for Chronic Disorders of Consciousness. Annaly Klinicheskoj i Jeksperimental’noj Nevrologii. 2020;14(1):5-16. (In Russ.). https://doi.org/10.25692/ACEN.2020.1.1
  2. Giacino JT, Katz DI, Schiff ND, et al. Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Neurology. 2018;91:450-460.  https://doi.org/10.1212/wnl.0000000000005926
  3. Working Party of the Royal College of Physicians. The vegetative state: guidance on diagnosis and management. A report of a working party of the Royal College of Physicians. Clin Med (Lond). 2019;3(3):249-254.  https://doi.org/10.7861/clinmedicine.3-3-249
  4. Kondziella D, Bender A, Diserens K, et al. European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness. Eur J Neurol. 2020;27(5):741-756.  https://doi.org/10.1111/ene.14151
  5. Laureys S, Celesia GG, Cohadon F, et al. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Medical. 2010;8:68.  https://doi.org/10.1186/1741-7015-8-68
  6. Van Erp WS, Lavrijsen JC, Vos M, et al.The vegetative state: prevalence, misdiagnosis, and treatment limitations. J Am Med Dir Assoc. 2015;16(1):85.e9–85.e14.  https://doi.org/10.1016/j.jamda.2014.10.014
  7. Piradov MA, Suponeva NA, Sergeev DV, et al. Structural and functional basis of chronic disorders of consciousness. The Annals Clinical and Experimental Neurology. 2018;12(5):6-15. (In Russ.). https://doi.org/10.25692/ACEN.2018.5.1
  8. Kondrat’eva EA, Avdjunina IA, Kondrat’ev AN, et al. Vegetative State: Difficulty in Identifying Consciousness and Predicting Outcome. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2016;71(4):273-280. (In Russ.). https://doi.org/10.15690/vramn728
  9. Schiff N, Giacino J, Laureys S. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019;18(6):600-614.  https://doi.org/10.1016/S1474-4422(19)30031-6
  10. Aleksandrova EV, Zaytsev OS, Potapov AA. Clinical syndromes of neurotransmitter system dysfunction in severe brain injury. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;115(7):40-46. (In Russ.). https://doi.org/10.17116/jnevro20151157140-46
  11. Kondrat’eva EA, Borovikova VN, Kondrat’ev SA, et al. The role of rivastigmine (exelon) in the treatment of consequences of cranial-brain trauma. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2009;109(1):55-58. (In Russ.).
  12. Thibaut A, Schiff N, Giacino J,et al. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019;18(6):600-614.  https://doi.org/10.1016/S1474-4422(19)30031-6
  13. Ciurleo R, Bramanti R, Calabro S. Pharmacotherapy for disorders of consciousness: are ‘awakening’ drugs really a possibility? Drugs. 2013;73(17):1849-1862. https://doi.org/10.1007/s40265-013-0138-8
  14. Calabro RS, Arico I, De Salvo S, et al. Transient awakening from vegetative state: is high — dose zolpidem more effective? Psychiatry Clin Neurosci. 2015;69(2):122-123.  https://doi.org/10.1111/pcn.12215
  15. Clauss RPW, Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation. 2006;21(2):23-28. 
  16. Dolce G, Lucca LF, Quintieri M, et al. Dysautonomia and clinical outcome in vegetative state. Journal Neurotrauma. 2008;25:1079-1082. https://doi.org/10.1089/neu.2008.0536
  17. Alexandrova EV, Tonoyan AS, Sychev AA, Kryukova KK. The activity of sympathoadrenal system in the acute phase of severe traumatic brain injury: the importance of neuroanatomical factors. Vestnik Rossijskogo Fonda Fundamental’nyh Issledovanij. 2016;90(2):41-49. (In Russ.).
  18. Grechko AV, Kiryachkov YuYu, Petrova MV. Modern aspects of the relationship between the functional state of the autonomic nervous system and clinical and laboratory indices of the body’s homeostasis in brain injuries. Vestnik Intensivnoj Terapii. 2018;(2):79-86. (In Russ.).
  19. Lucca LF, Lofaro D, Pignolo L, et al. Paroxysmal Sympathetic Hyperactivity Rate in Vegetative or Minimally Conscious State after Acquired Brain Injury Evaluated by Paroxysmal Sympathetic Hyperactivity Assessment Measure. J Neurotrauma. 2019;36(16):2430-2434. https://doi.org/10.1089/neu.2018.5963
  20. Giacino JT, Katz DI, Schiff ND, et al. Practice guideline update recommendations summary: disorders of consciousness: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Neurology. 2018;91(10):450-460.  https://doi.org/10.1212/WNL.0000000000005926
  21. Giacino JT, Whyte J, Bagiella E, et al. Placebo controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366(9):819-826.  https://doi.org/10.1056/NEJMoa1102609
  22. Gosseries O, Charland-Verville V, Thonnard M, et al. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Curr Pharm Des. 2014;20(26)):4167-4184.
  23. Kong M, Ba M, Ren C, et al. An updated meta-analysis of amantadine for treating dyskinesia in Parkinson’s disease. Oncotarget. 2017;8(34):57316-57326. https://doi.org/10.18632/oncotarget.17622
  24. Gao Y, Zhang Y, Li Z, et al.Persistent vegetative state after severe cerebral hemorrhage treated with amantadine: A retrospective controlled study. Medicine (Baltimore). 2020;99(33):e21822. https://doi.org/10.1097/MD.0000000000021822
  25. Zafonte R, Watanabe T, Mann N. Amantadine: a potential treatment for the minimally conscious state. Brain Injury. 1998;12(7):617-621.  https://doi.org/10.1080/02699059812238
  26. Reynolds JC, Rittenberger JC, Callaway CW. Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest. Resuscitation. 2013;84(6):818-824.  https://doi.org/10.1016/j.resuscitation.2012.11.014
  27. Lehnerer SM, Scheibe F, Buchert R, et al. Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhage. BMJ Case Reports. 2017;2017:bcr-2017-220305.
  28. Horiguchi J, Inami Y, Shoda T. Effects of long — term amantadine treatment on clinical symptoms and EEG of a patient in a vegetative state. Clinical Neuropharmacol. 1990;13(1):84-88.  https://doi.org/10.1097/00002826-199002000-00009
  29. Estraneo A, Pascarella A, Moretta P, et al. Clinical and electroencephalographic on — off e ect of amantadine in chronic non — traumatic minimally conscious state. J Neurol. 2015;262(6):1584-1586. https://doi.org/10.1007/s00415-015-7771-y
  30. Schnakers C, Hustinx R, Vandewalle G, et al. Measuring the effect of amantadine in chronic anoxic minimally conscious state. J Neurol Neurosurg Psychiatry. 2008;79(2):225-227.  https://doi.org/10.1136/jnnp.2007.124099
  31. Stelmaschuk S, Will MC, Meyers T. Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury. J Trauma Nurs. 2015;22(4):194-203.  https://doi.org/10.1097/JTN.0000000000000138
  32. Belkin AA, Shchegolev AV, Kondratyev AN, Bubnova ID. Use of amantadine sulfate (pk.-merz) during coma emergence: results of a multicenter study. Anesteziologija i Reanimatologija. 2008;(2):70-72. (In Russ.).
  33. Cheliapina MV, Sharova EV, Zaĭtsev OS. Clinical and electroencephalographic effects of amantadine sulfate (pk-merz) on consciousness disorders due to the severe traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2011;111(5):24-28. (In Russ.).
  34. Zaitsev OS, Tsarenko SV, Chelyapina MV, et al. Issues of the accounting of a weak neurotransmitter component in the pharmacotherapy of postcomatose states. Nevrologija, Nejropsihiatrija, Psihosomatika. 2016;8(4):87-90. (In Russ.).
  35. Zaitsev OS, Potapov AA, Likhterman LB, et al. Psychopathological consequences of severe diffuse and focal brain trauma. Russian Neurosurgical Journal named after Professor A.L. Polenova. 2018;(10Specvyp):90. (In Russ.).
  36. Chelyapina MV, Sharova EV, Zaitsev OS. Clinical-encephalographic syndrome of dopamine deficiency in patients with depressed consciousness after severe brain injury. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2015;115(4):9-15. (In Russ.). https://doi.org/10.17116/jnevro2015115419-15
  37. Mochalova EG, Legostaeva LA, Zimin AA, et al. The Russian version of Coma Recovery Scale-revised — a standardized method for assessment of patients with disorders of consciousness. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018(2):25-31. (In Russ.). https://doi.org/10.17116/jnevro20181183225-31
  38. Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale — Revised: measurement char — acteristics and diagnostic utility. Arch Phys Med Rehabil. 2004;85(12):2020-2029. https://doi.org/10.1016/j.apmr.2004.02.033
  39. Xia X, Yang Y, Guo Y, et al. Current Status of Neuromodulatory Therapies for Disorders of Consciousness. Neurosci Bull. 2018;34(4):615-625.  https://doi.org/10.1007/s12264-018-0244-4
  40. Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010;33(1):1-9.  https://doi.org/10.1016/j.tins.2009.11.002

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.